Verified· 2 sources

Immunovant Sciences GmbH

Summary

About the company

Immunovant Sciences GmbH is a clinical-stage immunology company developing anti‑FcRn therapies, including IMVT‑1402 and batoclimab, to reduce pathogenic IgG autoantibodies in autoimmune diseases. The product candidates are described as fully human monoclonal antibodies intended for subcutaneous administration with dosing that may be tailored to disease stage and severity.

AI-generated

Offering

Products & services

Industry:Research & Development

Outbound Leads by COHAGA

Looking for direct email addresses and phone numbers?

Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.

Discover Leadhub

Immunovant Sciences GmbH

About the company

Products & services

Looking for direct email addresses and phone numbers?

Immunovant Sciences GmbH

About the company

Products & services

Looking for direct email addresses and phone numbers?

No knowledge articles yet

Immunovant Sciences GmbH in comparison

Industry comparisons are coming soon

Similar companies